sepsi
seriou
lifethreaten
system
physic
ill
associ
toxic
due
invas
bloodstream
pathogen
invad
pathogen
bacteria
virus
rickettsia
fungi
parasit
earli
clinic
manifest
begin
inflamm
progress
circulatori
organ
dysfunct
associ
signific
hematopatholog
chang
welldefin
clinic
phenotyp
featur
includ
consumpt
thrombocytopenia
hemolyt
anemia
vascular
microthrombosi
multiorgan
dysfunct
syndrom
mod
coagulopathi
septic
shock
natur
defens
mechan
innat
adapt
immun
system
host
fig
effect
antimicrobi
therapi
favor
influenc
cours
sepsi
still
account
roughli
inhospit
death
discharg
hospic
recent
patholog
destruct
mechan
endotheli
system
fig
suspect
detriment
recoveri
septic
patient
contribut
high
morbid
mortal
although
role
endothelium
pathogenesi
sepsi
clearli
establish
yet
coagulopathi
propos
play
key
role
crosstalk
mechan
inflamm
coagul
result
system
endotheli
injuri
theori
particularli
attract
dissemin
intravascular
coagul
dic
commonli
occur
sepsi
howev
quotat
mark
place
dic
note
found
basi
poorli
establish
concept
hemostasi
recent
controversi
dic
claim
occur
due
uncontrol
system
activ
coagul
tissu
factor
tf
fviiainiti
hemostasi
manifest
thrombocytopenia
consumpt
coagulopathi
microvascular
thrombosi
mod
recur
question
come
light
true
charact
dic
although
hemostat
diseas
dic
defin
microthrombot
diseas
differ
macrothrombot
diseas
seen
arteri
thrombosi
deep
vein
thrombosi
author
made
reinterpret
dic
util
clinic
patholog
pathophysiolog
characterist
molecular
pathogenesi
determin
ident
dissemin
intravascular
microthrombosi
dit
seen
thrombot
thrombocytopen
purpura
ttp
like
syndrom
recent
public
time
term
dic
illfound
dic
use
interchang
throughout
articl
embrac
genuin
charact
dic
dit
pathophysiolog
mechan
true
dic
dic
dit
occur
hemostasi
clearli
establish
inde
better
understand
sepsisassoci
coagulopathi
becom
possibl
construct
twopath
unifi
theori
hemostasi
deriv
insight
endotheli
pathogenesi
lead
microthrombogenesi
ttplike
syndrom
novel
theori
simpl
easili
understand
propos
publish
updat
fig
effort
allow
us
use
term
dissemin
intravascular
microthrombosi
dit
instead
dic
endotheliopathyassoci
vascular
microthrombot
diseas
eavmtddit
distinct
diseas
entiti
associ
ttplike
syndrom
new
ident
dic
could
provid
paradigm
shift
manag
sepsi
util
target
therapi
improv
outcom
addit
thesi
along
twoactiv
theori
endothelium
fig
identifi
true
charact
dic
well
mechan
thrombogenesi
differ
phenotyp
thrombot
disord
hemostasi
sepsisinduc
endotheliopathi
poorli
understood
even
though
research
scientist
known
endotheli
injuri
play
promin
role
sepsi
mani
critic
ill
trauma
pregnanc
autoimmun
diseas
cancer
drugtoxin
lead
poorli
defin
seriou
coagulopathi
frequent
notic
earli
hematolog
manifest
occurr
unexplain
thrombocytopenia
critic
ill
patient
tcip
recent
clinic
mysteri
becom
evid
thrombocytopenia
develop
due
contribut
platelet
microthrombogenesi
consumpt
microthrombogenesi
process
form
microthrombi
compos
plateletunusu
larg
von
willebrand
factor
ulvwf
complex
follow
platelet
activ
endotheli
exocytosi
ulvwf
result
endotheliopathi
eavmtddit
sepsi
uniqu
hemostat
disord
develop
via
lone
activ
ulvwf
path
without
simultan
activ
tf
path
accord
twopath
unifi
theori
hemostasi
articl
pathophysiolog
mechan
promot
eavmtddit
sepsi
review
molecular
pathogenesi
endotheliopathi
hemostasi
discuss
clinic
phenotyp
variou
septic
syndrom
analyz
final
abl
recogn
eavmtddit
underli
clinic
diseas
associ
sepsisassoci
coagulopathi
oftentim
present
hematolog
phenotyp
ttplike
syndrom
activ
complement
system
normal
one
key
event
defens
mechan
pathogen
sepsi
protect
function
host
rapidli
identifi
elimin
invad
pathogen
whenev
possibl
opson
foreign
surfac
coval
attach
fulfil
three
major
function
pathogen
clearanc
phagocytosi
amplif
complement
activ
format
surfacebound
convertas
assembl
convertas
cleavag
induc
format
multiprotein
pore
complex
ie
membran
attack
complex
mac
lead
lysi
pathogen
although
major
role
complement
protect
function
host
innat
immun
defens
activ
complement
could
also
caus
destruct
action
host
endothelium
impact
cours
sepsi
illustr
fig
mac
exert
harm
effect
host
endotheli
cell
ec
unless
complement
regul
adequ
express
ec
protect
inhibit
polymer
mac
downregul
ec
due
either
gene
mutat
acquir
diseas
activ
termin
complement
mac
could
exert
destruct
effect
ec
sepsi
trauma
critic
ill
mac
attack
innoc
bystand
ec
channel
transmembran
pore
format
could
occur
endotheli
membran
trigger
endotheli
dysfunct
endothelium
locat
interfac
blood
subendotheli
tissu
set
extravascular
tissu
evt
monolay
endotheli
cell
distribut
vasculatur
organ
system
entir
human
bodi
vital
function
maintain
homeostasi
circulatori
network
also
provid
hemostasi
vascular
injuri
essenti
preserv
anatom
function
integr
endothelium
cost
prevent
unneed
intravascular
thrombosi
exposur
tf
present
setevt
could
caus
macrothrombosi
get
involv
vascular
organ
damag
hemostasi
play
critic
role
pathogenesi
sepsi
sepsi
occur
due
varieti
pathogen
caus
gener
endotheli
injuri
result
dissemin
natur
circulatori
system
lead
system
endotheliopathi
howev
sepsisinduc
endotheliopathi
trigger
function
chang
contribut
molecular
dysfunct
subsequ
partial
hemostasi
mediat
microthrombogenesi
unlik
local
traumat
intravascular
injuri
initi
bleed
hemostasi
due
combin
endotheli
setevt
damag
anatom
disrupt
vascular
endothelium
minim
sepsi
bleed
consequenti
endotheliopathi
confin
endothelium
tf
expos
thu
complement
activ
due
pathogen
endotoxin
provok
endotheli
dysfunct
promot
exocytosi
ulvwf
platelet
activ
initi
ulvwf
path
hemostasi
lead
microthrombogenesi
shown
fig
import
concept
understand
sepsisassoci
coagulopathi
sepsi
promot
lone
activ
ulvwf
path
without
activ
tf
path
sinc
setevt
damag
occur
thesi
base
microthrombogenesi
refut
current
theori
sepsisassoci
dic
occur
via
activ
tf
path
lead
fibrinogenesi
dic
reinterpret
dit
occur
via
activ
ulvwfiniti
thrombogenesi
associ
endotheliopathi
illustr
fig
dic
still
result
hemostasi
even
though
tf
involv
exocytosi
ulvwf
weibelpalad
bodi
activ
ulvwf
path
platelet
easili
recruit
ulvwf
show
extrem
high
affin
platelet
lone
activ
ulvwf
path
endotheliopathi
promot
format
microthrombi
lead
eavmtddit
thu
microthombi
dic
ttp
ttplike
syndrom
dic
inappropri
conceptu
fibrin
clot
diseas
produc
via
activ
tffviiainiti
cascadecellbas
coagul
illfound
dic
must
properli
renam
eavmtddit
hematolog
phenotyp
ttplike
syndrom
hand
consumpt
coagulopathi
acut
promyelocyt
leukemia
apl
occur
due
patholog
activ
aberr
tf
path
caus
tf
releas
leukem
promyelocyt
call
true
dic
true
dic
apl
made
dissemin
fibrin
clot
occur
without
vascular
injuri
hematolog
phenotyp
alway
character
hemorrhag
syndrom
hallmark
advanc
sepsi
microvascular
dysfunct
due
dissemin
microthrombi
compos
plateletulvwf
complex
multiorgan
promot
via
microthrombogenesi
pathophysiolog
mechan
induc
circulatori
dysfunct
lead
organ
ischemia
well
defin
clinic
medicin
vascular
microthrombosi
vmtd
addit
hypox
microvascular
dysfunct
endotheliopathi
caus
releas
variou
inflammatori
cytokin
bioactiv
biomark
ec
infect
differ
type
pathogen
unlik
adapt
immun
mechan
produc
antigenspecif
protect
antibodi
respons
pathogen
host
sepsisinduc
endotheliopathi
trigger
similar
endotheli
molecular
respons
without
specif
among
differ
type
pathogen
fig
tabl
endotheli
dysfunct
caus
independ
inflamm
differ
vascular
microthrombosi
manifest
inflamm
microthrombosi
univers
similar
among
class
type
pathogen
display
specif
howev
intrigu
question
clinic
organ
phenotyp
express
sepsi
differ
among
differ
host
also
among
differ
pathogen
exampl
organ
phenotyp
featur
sepsi
could
encephalopathi
myocard
pancreat
acut
respiratori
distress
syndrom
adren
insuffici
fulmin
hepat
failur
hemolyticurem
syndrom
hu
other
combin
due
differ
kind
vmtd
due
least
two
underli
genet
variabl
govern
individu
organ
suscept
host
affin
pathogen
specif
organ
endotheli
pathogenesi
sepsi
organ
phenotyp
express
variabl
among
differ
host
pathogen
well
differ
pathogen
organ
phenotyp
determin
two
main
endow
biolog
mechan
endotheli
heterogen
host
organotrop
pathogen
variabl
clinic
organ
phenotyp
syndrom
occur
seen
type
pathogen
exampl
hanta
viru
caus
cardiopulmonari
syndrom
heart
lung
shiga
toxinproduc
e
coli
present
hu
stechu
brain
bowel
kidney
neisseria
meningitid
incit
waterhousefriderichsen
syndrom
mening
adren
mening
also
organ
phenotyp
occur
differ
type
pathogen
clinician
use
mysteri
combin
clinic
term
hepatoren
syndrom
hepat
encephalopathi
cardiopulmonari
syndrom
often
without
identifi
involv
pathogen
even
though
sepsi
might
exist
perhap
oversimplifi
design
organ
phenotyp
imped
detect
underli
etiolog
organ
syndrom
modern
medic
literatur
exampl
mani
author
claim
one
organ
phenotyp
syndrom
caus
sever
organ
dysfunct
acut
renal
failur
encephalopathi
hepat
failur
sepsi
concept
endotheli
heterogen
organotrop
organ
local
phenotyp
vmtd
express
underli
patholog
support
biorgan
multiorgan
manifest
differ
phenotyp
diseas
eavmtd
likewis
addit
organ
phenotyp
often
design
extraorgan
manifest
eg
extraren
phenotyp
hu
extrapancreat
phenotyp
pancreat
extrapulmonari
phenotyp
acut
respiratori
distress
syndrom
ard
express
hemostat
diseas
eavmtd
inde
extraorgan
phenotyp
misrepresent
organ
phenotyp
express
associ
eavmtd
determin
combin
mechan
underli
endotheli
heterogen
host
organtissu
tropism
pathogentoxin
exampl
phenotyp
stechu
combin
result
genotyp
endotheli
heterogen
host
genotyp
tropism
stec
gastrointestin
tract
kidney
lung
brain
other
likewis
phenotyp
waterhousefriderichsen
syndrom
associ
neisseria
meningitid
express
result
combin
endotheli
heterogen
host
tissu
tropism
bacteria
adren
mening
concept
import
understand
genesi
mod
although
endotheliopathi
propos
main
patholog
promot
crosstalk
mechan
inflamm
coagul
sepsi
charact
blood
clot
thrombogenet
mechan
produc
coagulopathi
could
comprehens
crosstalk
theori
howev
complement
activ
critic
ill
affect
sever
molecular
function
ec
fit
well
endotheli
pathogenesi
sepsi
twoactiv
theori
endothelium
fig
propos
base
role
endotheliopathi
sepsi
also
critic
ill
endotheliopathi
occur
sepsi
endotheli
dysfunct
promot
activ
two
independ
endotheli
pathway
one
inflammatori
microthrombot
short
two
main
molecular
event
releas
inflammatori
cytokin
interleukin
il
tumor
necrosi
other
activ
platelet
exocytosi
ulvwf
former
trigger
inflamm
activ
inflammatori
pathway
latter
mediat
microthrombogenesi
via
activ
microthrombot
pathway
inflamm
promot
inflammatori
symptom
microthrombogenesi
mediat
thrombosi
produc
microthrombi
string
compos
plateletulvwf
complex
micothrombogenesi
activ
proteas
insuffici
cleav
excess
exocytos
ulvwf
without
mild
moder
underli
enzym
defici
occur
due
polymorph
heterozyg
mutat
microthrombi
string
produc
dit
smaller
larger
vasculatur
variou
organ
accord
novel
twopath
unifi
theori
fig
intravascular
injuri
normal
hemostasi
begin
simultan
independ
activ
ulvwf
path
tf
path
howev
endotheliopathi
associ
sepsi
ulvwf
path
normal
hemostasi
becom
activ
tf
avail
endothelium
endotheliopathi
sepsi
trigger
exocytosi
ulvwf
activ
platelet
produc
microthrombi
string
microthrombi
string
compos
plateletulvwf
complex
must
intrins
charact
blood
clot
dic
sepsi
occur
result
lone
activ
ulvwf
path
illustr
fig
therefor
concept
dic
sepsisassoci
coagulopathi
due
activ
tf
path
produc
fibrin
clot
incorrect
interpret
interpret
mistak
costli
thu
accord
twopath
unifi
theori
dic
eavmtddit
acut
dic
eavmtddit
hepat
coagulopathyhemorrhag
syndrom
eavmtddit
without
hemorrhag
syndrom
call
chronic
dic
previous
detail
endothelium
posit
interfac
blood
setevt
function
initi
site
foundri
produc
thrombu
follow
vascular
injuri
sepsisinduc
vascular
injuri
typic
limit
endothelium
ulvwf
path
becom
activ
caus
vascular
microthrombosi
smaller
larger
vasculatur
sepsisassoci
coagulopathi
shown
express
chang
antithrombot
prothrombot
marker
includ
tf
pathrel
marker
thrombin
antithrombin
thrombinantithrombin
complex
activ
protein
c
apc
tissu
factor
pathway
inhibitor
tfpi
thrombomodulin
tm
express
tf
path
marker
indirectli
support
role
activ
tf
path
pathogenesi
dic
howev
tf
pathrel
marker
explain
altern
mechan
includ
acut
dic
hepat
coagulopathi
combin
micromacrothrombot
syndrom
concomit
vascular
injuri
result
surgeri
vascular
access
perhap
commonli
mod
result
tissu
necrosi
especi
liver
kidney
lung
advanc
sever
sepsi
retrospect
express
tf
path
marker
sepsi
ascrib
secondari
event
unrel
primari
pathogenesi
activ
ulvwf
path
illustr
fig
patient
sever
sepsi
thrombin
gener
apc
tfpi
tm
true
marker
dic
interpret
secondari
marker
tf
path
true
marker
dic
activ
platelet
increas
fviii
activ
increas
vwf
excess
releas
ulvwf
upregul
collagen
bind
result
activ
ulvwf
path
wonder
clinic
trial
use
antithrombin
agent
apc
recombin
tfpi
recombin
tm
unsuccss
sepsisassoci
coagulopathi
like
due
fact
sepsisassoci
dic
true
dic
eavmtd
ie
ttplike
syndrom
caus
activ
ulvwf
path
endotheli
injuri
alon
induc
fibrinogenesi
provok
partial
hemostasi
lead
microthrombogenesi
produc
eavmtd
hand
aplassoci
dic
occur
due
activ
aberr
tf
path
true
dic
sepsisassoci
coagulopathi
author
believ
neutrophil
extracellular
trap
net
particip
thrombosi
unifi
stage
macrothrombu
problem
netosi
logic
hemostat
principl
inconsist
charact
thrombosi
vivo
anim
model
report
literatur
essenti
logic
format
thrombosi
normal
hemostasi
must
accompani
intravascular
injuri
without
thrombosi
form
activ
ulvwf
path
andor
tf
path
sine
qua
non
thrombogenesi
three
except
among
thrombot
disord
occur
without
vascular
injuri
ttp
aberr
thrombosi
vessel
injur
still
util
ulvwf
path
defici
apl
aberr
thrombosi
vessel
injur
still
util
tf
path
due
overexpress
tf
leukem
promyelocyt
heparininduc
thrombocytopenia
thrombosi
syndrom
patholog
thrombosi
vessel
injur
also
util
neither
ulvwf
path
tf
path
howev
know
cellular
molecular
trap
perhap
adhes
molecul
particip
hemostat
plug
thrombu
format
illustr
fig
blood
cellsmolecul
trap
comingl
process
blood
clot
format
macrothrombosi
unifi
stage
microthrombi
string
fibrin
clot
author
believ
netosi
activ
hemostat
process
passiv
one
associ
secondari
event
trap
blood
cell
molecul
dna
histon
process
thrombogenesi
support
twoactiv
theori
endothelium
twopath
unifi
theori
hemostasi
understand
sepsi
septic
shock
easili
defin
clinic
phenotyp
sepsisassoci
syndrom
via
two
independ
endotheli
pathway
promot
inflamm
microthrombogenesi
inflamm
clinic
phenotyp
endotheli
pathogenesi
sepsi
present
inflammatori
symptom
fever
chill
headach
myalgia
arthralgia
inflammatori
fever
occur
due
endogen
pyrogen
eg
cytokin
tnf
other
differ
infecti
fever
occur
due
exogen
pyrogen
eg
lipopolysaccharid
physiolog
defens
mechan
immun
system
shown
fig
clearli
two
kind
fever
combin
sepsi
one
infecti
fever
due
exogen
pyrogen
inflammatori
fever
caus
endotheliopathi
sepsi
fever
develop
due
combin
effect
exogen
pyrogen
pathogen
endogen
pyrogen
endotheliopathi
hand
nonsept
noninfecti
critic
ill
trauma
cancer
present
inflammatori
fever
via
endotheli
pathogenesi
emphas
sepsi
inflamm
caus
endotheliopathi
result
endotheliopathi
promot
activ
complement
system
fig
even
though
inflamm
vmtd
occur
simultan
endotheliopathi
inflamm
suffici
alter
activ
coagul
system
caus
microthrombogenesi
result
independ
molecular
process
interact
establish
molecular
level
although
simultan
occurr
inflamm
coagul
endotheliopathyassoci
sepsi
seem
consist
high
profil
crosstalk
theori
persuas
evid
base
hemostat
mechan
offer
inflamm
promot
microthrombosi
caus
dic
addit
note
inflamm
occur
aavmtd
even
though
plateletulvwf
complex
microthrombi
produc
microthrombogenesi
eavmtd
observ
also
support
inflamm
occur
endotheliopathi
inflamm
essenti
compon
lead
coagulationmicrothrombogenesi
differ
nonsept
critic
ill
sepsi
present
much
sever
inflamm
perhap
due
increas
cytokin
express
addit
loop
activ
circul
immun
cell
pathway
eg
lymphocyt
macrophag
monocyt
neutrophil
dendrit
cell
suggest
anoth
arrow
line
fig
pathway
could
explain
sever
inflamm
sir
common
sepsi
nonsept
critic
ill
inflamm
provok
inflammatori
symptom
sepsi
major
endotheli
pathogenesi
determin
sever
outcom
sepsi
elicit
microthrombosi
eavmtddit
sepsi
unexplain
thrombocytopenia
import
earli
telltal
sign
endotheliopathi
occur
ongo
microthrombogenesi
gener
consumpt
thrombocytopenia
tabl
thrombocytopenia
blame
often
heparin
critic
care
set
term
thrombocytopenia
critic
ill
patient
tcip
use
etiologyundetermin
thrombocytopenia
exclus
known
caus
thrombocytopenia
eg
heparininduc
drug
transfusionassoci
dic
associ
bone
marrow
suppressioncaus
hypersplenismrel
idiopath
autoimmuneinduc
other
often
blame
multifactori
caus
includ
consumpt
associ
thrombinmedi
platelet
activ
signific
mild
moder
tcip
earli
stage
sepsi
commonli
downplay
care
sick
septic
patient
pathogenesi
clearli
understood
hemorrhag
syndrom
uncommon
establish
tcip
common
predict
hematolog
featur
sepsisassoci
coagulopathi
note
tabl
occur
result
consumpt
thrombocytopenia
via
activ
ulvwf
path
increas
degre
tcip
typic
associ
advanc
vmtd
septic
patient
sinc
dic
associ
thrombocytopenia
hypofibrinogenemia
prolong
prothrombin
time
activ
partial
thromboplastin
time
posit
fibrin
degrad
product
tcip
attribut
consumpt
thrombocytopenia
well
consumpt
coagul
factor
contribut
fibrin
clot
howev
activ
tf
path
alon
consum
platelet
format
fibrin
meshesfibrin
clot
via
extrins
coagul
cascad
abnorm
coagul
profil
also
consist
hepat
coagulopathi
main
differenti
laboratori
featur
increas
fviii
markedli
decreas
fvii
eavmtddit
ie
dic
hepat
coagulopathi
markedli
decreas
fviii
normal
fvii
true
dic
eg
apl
coagul
characterist
serv
use
laboratori
diagnost
featur
true
dic
associ
apl
dic
associ
critic
ill
critic
care
set
signific
correl
observ
onset
durat
degre
thrombocytopenia
sever
outcom
critic
ill
observ
support
tcip
key
hematolog
phenotyp
play
import
role
endotheli
pathogenesi
sepsi
ttplike
syndrom
hematolog
phenotyp
eavmtddit
character
tcip
maha
associ
endotheliopathi
exclus
gene
mutat
associ
ttp
gavmtd
antibodyassoci
ttp
aavmtd
acquir
vmtd
nonimmun
type
develop
sepsi
critic
ill
ttplike
syndrom
common
often
mask
pathogenesi
well
appreci
clinician
often
classifi
report
medic
literatur
ttp
thrombot
microangiopathi
dic
hu
unclassifi
microthrombosi
commonli
ttplike
syndrom
sepsi
misdiagnos
dic
hematolog
featur
maha
often
uncov
mild
modest
anemia
bring
littl
attent
critic
ill
patient
ttp
similar
hematolog
phenotyp
eavmtd
ie
ttplike
syndrom
although
pathophysiolog
mechan
diametr
differ
ttplike
syndrom
ttp
occur
due
defici
typic
provok
microvascular
thrombosi
capillari
arteriol
kidney
brain
microthrombi
form
microcircul
becom
trap
microvasculatur
situ
promot
activ
aberr
ulvwf
path
hemostasi
without
intravascular
injuri
howev
ttplike
syndrom
eg
sepsisassoci
coagulopathi
occur
due
microthrombi
anchor
ec
smaller
larger
vasculatur
well
capillari
arteriol
provok
vascular
microthrombosi
promot
activ
normal
ulvwf
path
hemostasi
due
endotheli
injuri
unlik
ttp
creat
higher
stress
forc
red
cell
pass
sever
occlud
microvascular
space
bloodstream
perhap
microthrombi
string
eavmtd
anchor
ec
creat
milder
shear
stress
smaller
larger
vasculatur
produc
fewer
schistocyt
lead
mild
maha
result
less
appar
ttplike
syndrom
milder
shear
stress
like
reason
schistocyt
rare
hemolyt
anemia
covert
sepsi
thu
maha
less
commonli
unmask
hemolyt
anemia
import
clue
establish
sepsisassoci
vmtd
experienc
hematologist
care
evalu
thrombocytopen
patient
sepsi
high
index
suspicion
save
mani
live
diagnosi
ttplike
syndrom
uncov
earliest
stage
sepsi
regard
shear
stress
except
may
hemolyticurem
syndrom
associ
eavmtd
schistocyt
encount
larg
number
produc
sever
maha
could
due
rich
microvasculatur
present
within
kidney
even
though
ttplike
syndrom
ttp
patholog
character
dit
clinic
vmtd
genesi
clinic
featur
two
differ
type
vmtd
differ
present
tabl
variabl
phenotyp
featur
reason
ttplike
syndrom
easili
overlook
occur
result
eavmtd
sepsi
critic
ill
particularli
true
sepsi
trauma
postop
ttp
cancer
microthrombosi
may
occur
smaller
larger
vasculatur
variou
organ
eavmtd
exot
fanci
phenotyp
uncommon
shown
fig
unexplain
thrombocytopenia
hemolyt
anemia
could
first
clue
seriou
sepsi
evalu
immedi
determin
evid
mild
maha
ttplike
syndrom
patient
present
minim
number
schistocyt
tcip
sepsi
mod
might
develop
unusu
organ
lung
heart
pancrea
adren
digit
liver
muscl
other
well
brain
kidney
case
evid
hemolysi
reticulocytosi
hypohaptoglobinemia
indirect
hyperbilirubinemia
elev
lactic
acid
dehydrogenas
confirm
diagnosi
ttplike
syndrom
well
eavmtddit
mortal
sepsi
highli
correl
develop
mod
pathogenet
mechan
mod
circulatori
dysfunct
caus
vascular
microthrombosi
obstruct
blood
flow
decreas
oxygen
variou
organ
progress
hypoxia
would
lead
organ
failur
hasten
demis
patient
mechan
develop
differ
organ
phenotyp
mod
eavmtd
result
complex
interact
involv
endotheli
heterogen
host
tropism
pathogen
endotheli
heterogen
govern
endow
molecul
endothelium
tropism
differ
type
pathogen
determin
invas
pathogen
patient
uniqu
express
host
endothelium
specif
affin
pathogen
differ
host
organ
appear
creat
variabl
organ
syndrom
figur
summar
exampl
mod
variou
organ
known
occur
eavmtd
organ
exampl
show
affin
pathogen
could
brain
encephalopathi
due
variou
enceph
virus
lung
acut
respiratori
distress
syndrom
ard
due
sever
acut
respiratori
syndrom
sar
cov
middl
east
respiratori
syndrom
mer
cov
kidney
hemolyticurem
syndrom
hu
due
stec
other
current
pathophysiolog
mechan
organ
dysfunct
thought
result
direct
invas
pathogen
tissu
involv
organ
mechan
may
lead
combin
compromis
endothelium
setevt
trigger
cellul
abscess
macrothrombsi
howev
endotheli
breach
occur
uncommonli
although
sepsisinduc
endotheliopathi
univers
typic
setevt
compromis
sepsi
mod
occur
result
microthrombosi
caus
revers
hypoxia
organ
unless
advanc
termin
multiorgan
failur
organ
dysfunct
syndrom
sepsi
includ
fulmin
hepat
failur
fhf
acut
liver
failur
acut
necrot
pancreat
myocardi
infarct
acut
adren
insuffici
rhabdomyolysi
may
revers
improv
sepsi
unless
necrot
gangren
chang
develop
seen
tissu
gangren
peripher
digit
ischem
syndrom
seriou
combin
phenotyp
syndrom
underli
pathogenesi
still
debat
includ
hepat
encephalopathi
hepatoren
syndrom
hepat
coagulopathi
cardiopulmonari
syndrom
clinician
take
advantag
hemostat
natur
vmtd
therapeut
approach
consid
sinc
phenotyp
mod
clinic
syndrom
occur
due
vascular
microthrombosi
stress
ard
hu
fhf
rhabdomyolysi
acut
pancreat
caus
sepsisassoci
coagulopathi
endotheliopathi
instead
organ
phenotyp
manifest
sepsisassoci
coagulopathi
develop
due
complementinduc
endotheliopathi
subsequ
microthrombogenesi
exampl
case
report
medic
literatur
often
cite
pancreat
respons
ttplike
syndrom
caus
acut
renal
failur
encephalopathi
fhf
articl
state
ttplike
syndrom
ie
eavmtd
caus
pancreat
well
organ
dysfunct
septic
shock
seriou
wellknown
sepsisassoci
syndrom
present
alter
mental
state
hypotens
associ
hyperthermiahypothermia
tachycardiatachypnea
oliguria
precipit
circulatori
failur
hypotens
suggest
advanc
state
multipl
vital
organ
failur
therefor
septic
shock
ascrib
underli
circulatori
cellular
metabol
abnorm
profound
enough
substanti
increas
mortal
although
multipl
organ
dysfunct
take
place
due
hypoxia
induc
dit
pathophysiolog
mechan
septic
shock
still
unsolv
riddl
answer
question
hypotens
incit
dit
kind
cellular
metabol
abnorm
develop
septic
shock
accord
twoactiv
theori
endothelium
microthrombi
string
anchor
ec
within
vasculatur
trigger
circulatori
dysfunct
difficult
incrimin
onset
hypotens
shock
hypoxia
inflamm
yet
unidentifi
metabol
molecul
howev
enough
evid
accumul
septic
shock
repres
adren
crisisacut
adren
insuffici
aai
associ
adren
hemorrhag
andor
necrosi
due
dit
aai
seriou
form
mod
exampl
tropism
pathogen
neisseria
meningitid
adren
gland
caus
waterhousefriderichsen
syndrom
inde
dic
present
renam
ttplike
syndrom
eavmtddit
associ
waterhousefriderichsen
syndrom
role
aai
septic
shock
establish
propos
pathogenesi
illustr
detail
fig
proposit
adren
crisisaai
result
microthrombosi
would
signific
ramif
manag
septic
shock
look
back
enigmat
natur
true
dic
ie
aplassoci
coagulopathi
dic
eg
dic
acut
dic
chronic
dic
critic
ill
dit
eg
vmtd
ttp
gavmtd
aavmtd
ttplike
syndrom
eavmtd
hu
thrombot
microangiopathi
concept
ambigu
contradict
one
anoth
addit
mani
disord
occur
seriou
lifethreaten
complic
sepsi
critic
ill
hemostat
diseas
present
microthrombosi
microthrombocoagulopathi
without
clear
distinct
complex
contribut
confus
exact
natur
coagulopathi
thrombopathi
sepsi
medic
literatur
poorli
defin
sepsisassoci
coagulopathi
often
call
dic
sometim
even
profici
coagul
specialist
express
uneasi
use
term
dic
diagnosi
pathogenesi
could
unequivoc
establish
fatal
high
known
effect
treatment
avail
ambigu
concept
dic
must
contribut
poor
outcom
treatment
sepsi
includ
unsatisfactori
clinic
trial
inappropri
anticoagul
antithrombot
therapi
plasma
therapi
recent
concept
dic
reapprais
dit
clinic
diseas
eavmtddit
move
dic
column
dic
eavmtddit
leftov
true
dic
occur
apl
coagulopathi
associ
hemorrhag
syndrom
fibrin
clot
form
fibrinogenesi
via
extrins
coagul
cascad
activ
aberr
tf
path
true
dic
associ
apl
intrins
charact
blood
clot
fibrin
clot
made
fibrin
mesh
via
activ
tf
path
dic
sepsisassoci
coagulopathi
intrins
charact
blood
clot
microthrombi
compos
plateletulvwf
string
via
activ
ulvwf
path
therefor
sepsisassoci
coagulopathi
dic
chronic
dic
eavmtddit
ie
ttplike
syndrom
thu
acut
dic
eavmtddit
hepat
coagulopathi
hope
effect
treatment
antimicrothrombot
therapi
could
becom
avail
save
live
sepsisassoci
eavmtddit
sinc
dic
coin
dic
donald
mckay
work
clinician
coagul
specialist
pathophysiolog
mechan
dic
eventu
identifi
endotheliopathyassoci
microthrombosi
final
analysi
molecular
event
hemostasi
pathogenesi
eavmtd
explain
mechan
microvascular
thrombosisvascular
microthrombosi
thrombohemorrhag
syndrom
abnorm
coagul
profil
dic
coexist
dic
liver
diseas
acut
dic
endotheli
contribut
hemostasi
role
ulvwf
path
thrombogenesi
also
explain
mean
confus
dic
marker
thrombin
gener
thrombinantithrombin
complex
tissu
factor
pathway
inhibitor
activ
protein
c
thrombomodulin
marker
dic
secondari
event
vmtd
tissu
damag
mod
vascular
access
hospit
hepat
coagulopathi
combin
micromacrothrombot
syndrom
differenti
featur
sepsisassoci
dic
thrombocoagulopathi
summar
tabl
sinc
dic
sepsi
coagul
disord
result
fibrin
clot
microthrombot
disord
dit
result
microthrombi
paradigm
shift
dic
eavmtddit
abl
identifi
mechan
microthrombogenesi
true
charact
microthrombi
continu
dic
debat
date
natur
final
endow
us
insight
help
construct
pathophysiolog
mechan
normal
hemostasi
thrombogenesi
fig
sir
defin
sever
febril
toxic
clinic
syndrom
associ
variabl
organ
dysfunct
nonspecif
dread
insult
septic
andor
nonsept
origin
clinic
descript
syndrom
includ
sever
inflamm
mod
associ
variou
organ
phenotyp
manifest
due
dissemin
microthrombosi
vascular
hypoxia
ard
husacut
renal
failur
fhfacut
liver
failur
accord
twoactiv
theori
endothelium
sir
easili
recogn
context
ultim
manifest
sever
inflamm
present
fig
sir
repres
intens
clinic
syndrom
due
combin
activ
inflammatori
pathway
promot
cytokin
releas
storm
microthrombot
pathway
trigger
platelet
activ
endotheli
exocytosi
result
eavmtddit
sir
common
sever
sepsi
compar
nonsept
critic
ill
tcip
occur
often
due
platelet
consumpt
earli
marker
sir
sepsi
sever
thrombocytopenia
like
associ
combin
syndrom
sir
mod
uncommon
uniqu
mysteri
thrombosi
syndrom
often
occur
sepsi
welldemarc
symmetr
peripher
gangren
shown
fig
gangren
develop
dic
well
document
literatur
unexplain
complic
ttplike
syndrom
microthrombosi
alon
caus
gangren
pathogenesi
unknown
author
attribut
combin
micromacrothrombot
syndrom
becom
obviou
understand
twopath
unifi
theori
hemostasi
sinc
eavmtddit
compos
plateletulvwf
complex
via
lone
activ
ulvwf
path
tf
pathrel
thrombin
fibrin
marker
express
eavmtddit
howev
sepsisassoci
coagulopathi
addit
tf
path
activ
may
occur
due
incident
vascular
damag
extend
endothelium
setevt
may
seen
advanc
stage
mod
hepat
coagulopathi
seriou
condit
multipl
macrothrombi
associ
gangren
develop
sepsisassoci
coagulopathi
eavmtd
disord
typic
present
welldemarc
symmetr
peripher
gangren
involv
digit
extrem
disord
term
symmetr
peripher
gangren
peripher
digit
ischem
syndrom
postop
patient
also
extens
purpura
ischem
gangren
seen
septic
patient
typic
occur
thrombophil
neonat
purpura
fulminan
consist
combin
micromacrothrombot
syndrom
sever
sepsisassoci
complex
thrombopath
disord
suggest
addit
vascular
injuri
andor
underli
thrombophil
state
protein
c
defici
protein
defici
fvleiden
play
role
provok
combin
micromacrothrombot
syndrom
current
symmetr
peripher
gangren
sepsi
suspect
occur
due
vasopressor
agent
use
septic
shock
howev
better
explan
rest
combin
hemostasi
microthrombogenesi
macrothrombogenesi
although
latter
secondari
event
occur
complic
eavmtddit
pathophysiolog
mechan
combin
micromacrothrombot
syndrom
easili
support
twopath
unifi
theori
typic
first
setup
hospit
admiss
patient
sepsi
provok
eavmtddit
patient
would
need
multipl
venou
arteri
access
andor
perhap
surgeri
hospit
vascular
intervent
caus
intravascular
injuri
lead
damag
setevt
releas
tf
activ
tf
path
lead
fibrinogenesi
form
fibrin
clot
circul
sinc
ongo
ulvwf
path
alreadi
activ
endotheliopathi
microthrombi
string
form
fibrin
clot
microthrombi
would
unifi
produc
intravascular
macrothrombi
via
macrothrombogenesi
macrothrombi
could
travel
peripher
arteri
vasculatur
small
larg
arteri
digit
extrem
combin
micromacrothrombot
syndrom
could
lead
multipl
welldemarc
peripher
symmetr
gangren
distal
vascular
tree
therapeut
plasma
exchang
tpe
effect
treatment
ttplike
syndrom
therapi
promptli
appli
perhap
untim
treatment
tpe
due
delay
establish
diagnosi
main
factor
poor
outcom
eavmtd
rational
util
tpe
ttplike
syndrom
cleav
andor
remov
excess
ulvwf
patient
plasma
replac
normal
donor
plasma
contain
adequ
amount
inde
tpe
extens
util
clinician
patient
thought
atyp
ttp
ttplike
syndrom
thrombot
microangiopathi
retrospect
review
mani
report
case
studi
found
clinic
featur
eavmtddit
know
tpe
effect
ttplike
syndrom
includ
dic
recommend
patient
thrombocytopenia
maha
withwithout
mod
tpe
lifesav
measur
ttplike
syndrom
time
far
sepsi
concern
tpe
util
treatment
sepsi
respect
clinic
trial
pilot
studi
well
case
studi
studi
done
even
without
understand
concept
microthrombogenesi
mechan
endotheli
pathogenesi
interestingli
tpe
seem
effect
plasma
filtrat
therapi
sepsi
addit
tpe
also
effect
dic
mod
respons
sepsi
tpe
also
support
septic
syndrom
manifest
dit
tpe
expect
effect
therapi
util
earliest
possibl
time
septic
syndrom
atyp
hu
ahu
wellrecogn
syndrom
associ
dysfunct
like
unprotect
complement
activ
effect
anticompl
therapi
establish
ahu
sinc
complement
activ
sepsi
kill
invad
pathogen
inhibit
anticompl
therapi
earli
immun
defens
system
theoret
anticompl
therapi
eculizumab
contraind
sepsi
time
know
precis
role
complement
advanc
stage
endotheliopathi
howev
potenti
benefit
nonpathogen
relat
eavmtd
trauma
toxin
envenom
interest
specul
tpe
surrog
form
antimicrothrombot
therapi
highli
timesensit
effect
treatment
howev
treatment
delay
due
technic
limit
andor
becom
complic
vascular
volum
overload
electrolyt
imbal
outcom
tpe
like
unfavor
septic
syndrom
critic
ill
theoret
ideal
treatment
target
therapi
one
antimicrothrombot
agent
recombin
earliest
possibl
time
studi
shown
effect
cleav
plateletulvwf
complex
vitro
antimicrothrombot
therapi
advoc
vivo
use
potenti
benefit
acquir
ttp
ttplike
syndrom
recombin
use
phase
studi
gavmtd
ie
hereditari
ttp
time
sinc
proteolyt
activ
ulvwf
well
establish
investig
agent
avail
clinic
trial
eavmtd
includ
septic
syndrom
dic
well
mod
caus
eavmtd
latest
studi
acquir
ttp
antimicrothrombot
agent
caplacizumab
antivon
willebrand
factor
vwf
nanobodi
shown
signific
clinic
benefit
posit
result
also
support
role
ulvwf
path
ttplike
syndrom
well
eavmtddit
antimicrothrombot
therapi
util
close
monitor
platelet
count
intravascular
hemolysi
evalu
organ
dysfunct
streamlin
therapeut
trial
recombin
propos
patient
septic
syndrom
associ
eavmtddit
soon
possibl
endotheli
pathogenesi
sepsi
septic
shock
due
lone
activ
ulvwf
path
without
activ
tf
path
hemostasi
molecular
pathogenesi
sepsi
clearli
establish
dual
concept
base
twopath
unifi
theori
hemostasi
twoactiv
theori
endothelium
sepsi
complement
activ
destruct
ec
host
provok
endotheliopathi
promot
two
independ
molecular
event
lead
activ
inflammatori
pathway
microthrombot
pathway
result
endotheliopathi
associ
inflamm
eavmtd
present
ttplike
syndrom
big
pictur
physiolog
protect
immun
system
guard
host
elimin
invad
pathogen
patholog
destruct
endotheli
system
detriment
host
protect
immun
system
compromis
antibiot
optim
effect
better
understand
sepsisassoci
coagulopathi
microthrombopathi
effect
treatment
could
design
target
microthrombot
pathway
endotheli
pathogenesi
